Coblopasvir

DB15315InvestigationalSmall molecule

Coblopasvir is under investigation in clinical trial NCT03416491 (Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C).

Chemical structure of Coblopasvir
Mechanism
Curator reviewed
Formula / weight
C41H50N8O8 · 782.899 g/mol (avg)

Resolves to

Compound
UNII67XWL3R65WCAS1312608-46-0
Clinical / RWD
ATCJ05AP12
Structure
InChIKeyJBYJTCVXUMWTJJ-YRCZKMHPSA-NSMILESCOC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C2=CN=C(N2)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C2=C1OCO2
Targets
Q5L478NS5A

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Coblopasvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In